Nr. Aiken et al., 31P NMR SPECTROSCOPIC STUDIES OF THE EFFECTS OF CYCLOPHOSPHAMIDE ON PERFUSED RIF-1 TUMOR-CELLS, Magnetic resonance in medicine, 31(3), 1994, pp. 241-247
To determine whether direct cellular effects of chemotherapy are respo
nsible for P-31 NMR spectral changes observed in treated tumors in viv
o, RIF-I fibrosarcoma cells were examined in vitro before, during, and
after treatment with 4-hydroperoxycyclophosphamide (4-HC), an activat
ed form of cyclophosphamide. When RIF-1 cells were treated with 4-HC i
n a metabolically stable but nonproliferating state, the P-31 NMR spec
tra were identical with those of untreated cells for up to 70 h. When
actively proliferating RIF-1 cells were treated with 4-HC, the intensi
ties of the nucleotide triphosphate resonances, which increased linear
ly during control cell growth, remained constant for 50 h or longer. T
hese studies demonstrate that the bioenergetic improvement observed fo
llowing treatment of RIF-1 tumors in vivo [S.-J. Li, J.P. Wehrle, S.S.
Rajan, R.G. Steen, J.D. Glickson, and J. Hilton, Cancer Res. 48, 4736
(1988)] does not result from direct effects of cyclophosphamide metab
olites on RIF-1 cell metabolism, but rather from indirect effects of t
reatment on tumor or host physiology.